Literature DB >> 34073844

Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema.

Susan P Mollan1, Yu Jeat Chong1, Olivia Grech2,3, Alex J Sinclair2,3,4, Benjamin R Wakerley2,3,4.   

Abstract

The pseudotumor cerebri syndrome embraces disorders characterised by raised intracranial pressure, where the commonest symptom is headache (90%). Idiopathic intracranial hypertension without papilloedema (IIHWOP) is increasingly recognised as a source of refractory headache symptoms and resultant neurological disability. Although the majority of patients with IIHWOP are phenotypically similar to those with idiopathic intracranial hypertension (IIH), it remains uncertain as to whether IIHWOP is nosologically distinct from IIH. The incidence, prevalence, and the degree of association with the world-wide obesity epidemic is unknown. Establishing a diagnosis of IIHWOP can be challenging, as often lumbar puncture is not routinely part of the work-up for refractory headaches. There are published diagnostic criteria for IIHWOP; however, some report uncertainty regarding a pathologically acceptable cut off for a raised lumbar puncture opening pressure, which is a key criterion. The literature provides little information to help guide clinicians in managing patients with IIHWOP. Further research is therefore needed to better understand the mechanisms that drive the development of chronic daily headaches and a relationship to intracranial pressure; and indeed, whether such patients would benefit from therapies to lower intracranial pressure. The aim of this narrative review was to perform a detailed search of the scientific literature and provide a summary of historic and current opinion regarding IIHWOP.

Entities:  

Keywords:  diplopia; headache; idiopathic intracranial hypertension without papilloedema; intracranial pressure; lumbar puncture; migraine; optical coherence tomography; pseudotumour cerebri; telemetric monitoring; tinnitus

Year:  2021        PMID: 34073844     DOI: 10.3390/life11060472

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  72 in total

1.  Raised intracranial pressure in those presenting with headache.

Authors:  Susan P Mollan; David Spitzer; David J Nicholl
Journal:  BMJ       Date:  2018-10-04

2.  Association of MRI findings and visual outcome in idiopathic intracranial hypertension.

Authors:  Amit M Saindane; Beau B Bruce; Bryan D Riggeal; Nancy J Newman; Valérie Biousse
Journal:  AJR Am J Roentgenol       Date:  2013-08       Impact factor: 3.959

3.  Idiopathic intracranial hypertension without papilledema.

Authors:  J Marcelis; S D Silberstein
Journal:  Arch Neurol       Date:  1991-04

4.  Do Optic Canal Dimensions Measured on CT Influence the Degree of Papilloedema and Visual Dysfunction in Idiopathic Intracranial Hypertension?

Authors:  Nicholas T Skipper; Mark S Igra; Revelle Littlewood; Paul Armitage; Peter J Laud; Susan P Mollan; Basil Sharrack; Irene M Pepper; Ruth Batty; Daniel J A Connolly; Simon J Hickman
Journal:  Neuroophthalmology       Date:  2018-06-26

5.  Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache.

Authors:  F Bono; D Messina; C Giliberto; D Cristiano; G Broussard; S D'Asero; F Condino; L Mangone; C Mastrandrea; F Fera; A Quattrone
Journal:  J Neurol       Date:  2008-05-06       Impact factor: 4.849

6.  Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis.

Authors:  R I Farb; I Vanek; J N Scott; D J Mikulis; R A Willinsky; G Tomlinson; K G terBrugge
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

Review 7.  Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis.

Authors:  Robin M van Dongen; Ronald Zielman; Marek Noga; Olaf M Dekkers; Thomas Hankemeier; Arn Mjm van den Maagdenberg; Gisela M Terwindt; Michel D Ferrari
Journal:  Cephalalgia       Date:  2016-09-30       Impact factor: 6.292

8.  Intracranial pressure in unresponsive chronic migraine.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Paolo Cappabianca; Mario Quarantelli; Felice Esposito; Giuseppe Cardillo; Vincenzo Bonavita
Journal:  J Neurol       Date:  2014-04-30       Impact factor: 4.849

9.  Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain?

Authors:  Andreas Yiangou; James Mitchell; Keira Annie Markey; William Scotton; Peter Nightingale; Hannah Botfield; Ryan Ottridge; Susan P Mollan; Alexandra J Sinclair
Journal:  Cephalalgia       Date:  2018-06-17       Impact factor: 6.292

10.  Erenumab for headaches in idiopathic intracranial hypertension: A prospective open-label evaluation.

Authors:  Andreas Yiangou; James L Mitchell; Claire Fisher; Julie Edwards; Vivek Vijay; Zerin Alimajstorovic; Olivia Grech; Gareth G Lavery; Susan P Mollan; Alexandra J Sinclair
Journal:  Headache       Date:  2020-12-14       Impact factor: 5.887

View more
  1 in total

1.  Evolving Evidence in Idiopathic Intracranial Hypertension.

Authors:  Susan P Mollan; Heather E Moss; Steffen Hamann
Journal:  Life (Basel)       Date:  2021-11-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.